INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS

被引：0
|
作者：
Carra, G. [1 ]
Panuzzo, C. [1 ]
Crivellaro, S. [1 ]
Torti, D. [2 ]
Parvis, G. [2 ]
Familiari, U. [3 ]
Volante, M. [3 ,4 ]
Morena, D. [4 ]
Lingua, M. F. [4 ]
Brancaccio, M. [5 ]
Guerrasio, A. [1 ]
Pandolfi, P. P. [6 ]
Saglio, G. [1 ]
Taulli, R. [4 ]
Morotti, A. [1 ]
机构：
[1] San Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Orbassano, Italy
[2] San Luigi Gonzaga Hosp, Hematol, Div Internal Med, Orbassano, Italy
[3] San Luigi Gonzaga Hosp, Div Pathol, Orbassano, Italy
[4] Univ Turin, San Luigi Gonzaga Hosp, Div Pathol, Dept Oncol, Orbassano, Italy
[5] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy
[6] Harvard Med Sch, Canc Genet Program, Beth Israel Deaconess Canc Ctr, Dept Med & Pathol,Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1024
引用
收藏
页码：421 / 421
页数：1
相关论文
共 50 条
  • [21] A unique spectrum of p53 mutations in B-cell chronic lymphocytic leukemia distinct from that of other lymphoid malignancies
    Newcomb, EW
    ElRouby, S
    Thomas, A
    MOLECULAR CARCINOGENESIS, 1995, 14 (04) : 227 - 232
  • [22] IL-24 Induces Apoptosis of Chronic Lymphocytic Leukemia B Cells Engaged into the Cell Cycle through Dephosphorylation of STAT3 and Stabilization of p53 Expression
    Sainz-Perez, Alexander
    Gary-Gouy, Helene
    Gaudin, Francoise
    Maarof, Ghyath
    Marfaing-Koka, Anne
    de Revel, Thierry
    Dalloul, Ali
    JOURNAL OF IMMUNOLOGY, 2008, 181 (09): : 6051 - 6060
  • [23] Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells
    Lin, K.
    Rockliffe, N.
    Johnson, G. G.
    Sherrington, P. D.
    Pettitt, A. R.
    ONCOGENE, 2008, 27 (17) : 2445 - 2455
  • [24] Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells
    K Lin
    N Rockliffe
    G G Johnson
    P D Sherrington
    A R Pettitt
    Oncogene, 2008, 27 : 2445 - 2455
  • [25] Non-genotoxic MDM2 inhibition selectively induces a pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cells
    Ciardullo, Carmela
    Aptullahoglu, Erhan
    Woodhouse, Laura
    Lin, Wei-Yu
    Wallis, Jonathan P.
    Marr, Helen
    Marshall, Scott
    Bown, Nick
    Willmore, Elaine
    Lunec, John
    HAEMATOLOGICA, 2019, 104 (12) : 2429 - 2442
  • [26] UCN-O1: A promising new agent for B-cell chronic lymphocytic leukemia (B-CLL) that induces apoptosis independent of p53 status.
    Byrd, JC
    Shinn, CA
    Bedi, A
    Waselenko, JK
    Flinn, IW
    Diehl, LF
    Sausville, E
    Grever, MR
    BLOOD, 1997, 90 (10) : 4125 - 4125
  • [27] The α1-adrenoceptor antagonist terazosin induces prostate cancer cell death through a p53 and Rb independent pathway
    Xu, KX
    Wang, XH
    Ling, PMT
    Tsao, SW
    Wong, YC
    ONCOLOGY REPORTS, 2003, 10 (05) : 1555 - 1560
  • [28] KN-93 inhibits androgen receptor activity and induces cell death irrespective of p53 and Akt status in prostate cancer
    Rokhlin, Oskar W.
    Guseva, Natalya V.
    Taghiyev, Agshin F.
    Glover, Rebecca A.
    Cohen, Michael B.
    CANCER BIOLOGY & THERAPY, 2010, 9 (03) : 223 - 234
  • [29] PRIMA-1, a reactivator of mutant p53, induces antileukemic effects in cells from patients with chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML).
    Nahi, H
    Merup, M
    Lehmann, S
    Mollgard, L
    Wiman, C
    Paul, C
    BLOOD, 2003, 102 (11) : 604A - 605A
  • [30] Inhibition of PAX2 expression results in alternate cell death pathways in prostate cancer cells differing in p53 status
    Gibson, Willietta
    Green, Ashley
    Bullard, Rebecca S.
    Eadd, Andre C.
    Donald, Carlton D.
    CANCER LETTERS, 2007, 248 (02) : 251 - 261
12345